331 related articles for article (PubMed ID: 20188164)
1. HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide.
Banerjee A; Zhang X; Manda KR; Banks WA; Ercal N
Free Radic Biol Med; 2010 May; 48(10):1388-98. PubMed ID: 20188164
[TBL] [Abstract][Full Text] [Related]
2. A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells.
Price TO; Uras F; Banks WA; Ercal N
Exp Neurol; 2006 Sep; 201(1):193-202. PubMed ID: 16750528
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Tat and methamphetamine co-induced oxidative cellular injury is mitigated by N-acetylcysteine amide (NACA) through rectifying mTOR signaling.
Zeng XF; Li Q; Li J; Wong N; Li Z; Huang J; Yang G; Sham PC; Li SB; Lu G
Toxicol Lett; 2018 Dec; 299():159-171. PubMed ID: 30261225
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine and HIV-Tat Protein Synergistically Induce Oxidative Stress and Blood-Brain Barrier Damage via Transient Receptor Potential Melastatin 2 Channel.
Huang J; Zhang R; Wang S; Zhang D; Leung CK; Yang G; Li Y; Liu L; Xu Y; Lin S; Wang C; Zeng X; Li J
Front Pharmacol; 2021; 12():619436. PubMed ID: 33815104
[TBL] [Abstract][Full Text] [Related]
5. Protective Effects of Ginsenoside Rb1 against Blood-Brain Barrier Damage Induced by Human Immunodeficiency Virus-1 Tat Protein and Methamphetamine in Sprague-Dawley Rats.
Li J; Zeng B; Hu X; Li Z; Zhang D; Yang G; Dai J; Zeng X
Am J Chin Med; 2018; 46(3):551-566. PubMed ID: 29690789
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.
Price TO; Ercal N; Nakaoke R; Banks WA
Brain Res; 2005 May; 1045(1-2):57-63. PubMed ID: 15910762
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine amide protects against methamphetamine-induced tissue damage in CD-1 mice.
Zhang X; Tobwala S; Ercal N
Hum Exp Toxicol; 2012 Sep; 31(9):931-44. PubMed ID: 22354084
[TBL] [Abstract][Full Text] [Related]
8. N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells.
Zhang X; Banerjee A; Banks WA; Ercal N
Brain Res; 2009 Jun; 1275():87-95. PubMed ID: 19374890
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse.
Mahajan SD; Aalinkeel R; Sykes DE; Reynolds JL; Bindukumar B; Adal A; Qi M; Toh J; Xu G; Prasad PN; Schwartz SA
Brain Res; 2008 Apr; 1203():133-48. PubMed ID: 18329007
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.
Nookala AR; Schwartz DC; Chaudhari NS; Glazyrin A; Stephens EB; Berman NEJ; Kumar A
Brain Behav Immun; 2018 Jul; 71():37-51. PubMed ID: 29729322
[TBL] [Abstract][Full Text] [Related]
11. Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain.
Flora G; Lee YW; Nath A; Hennig B; Maragos W; Toborek M
Exp Neurol; 2003 Jan; 179(1):60-70. PubMed ID: 12504868
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteineamide (NACA) prevents inflammation and oxidative stress in animals exposed to diesel engine exhaust.
Banerjee A; Trueblood MB; Zhang X; Manda KR; Lobo P; Whitefield PD; Hagen DE; Ercal N
Toxicol Lett; 2009 Jun; 187(3):187-93. PubMed ID: 19429263
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells.
Ramirez SH; Potula R; Fan S; Eidem T; Papugani A; Reichenbach N; Dykstra H; Weksler BB; Romero IA; Couraud PO; Persidsky Y
J Cereb Blood Flow Metab; 2009 Dec; 29(12):1933-45. PubMed ID: 19654589
[TBL] [Abstract][Full Text] [Related]
14. Effects of HIV-1 gp120 and TAT-derived microvesicles on endothelial cell function.
Hijmans JG; Stockelman K; Levy M; Brewster LM; Bammert TD; Greiner JJ; Connick E; DeSouza CA
J Appl Physiol (1985); 2019 May; 126(5):1242-1249. PubMed ID: 30789287
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine toxicity and its implications during HIV-1 infection.
Silverstein PS; Shah A; Gupte R; Liu X; Piepho RW; Kumar S; Kumar A
J Neurovirol; 2011 Oct; 17(5):401-15. PubMed ID: 21786077
[TBL] [Abstract][Full Text] [Related]
16. Regional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration.
Pang X; Panee J; Liu X; Berry MJ; Chang SL; Chang L
J Neuroimmune Pharmacol; 2013 Jun; 8(3):691-704. PubMed ID: 23546885
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) on glutamate and lead-induced toxicity in CD-1 mice.
Penugonda S; Ercal N
Toxicol Lett; 2011 Feb; 201(1):1-7. PubMed ID: 21145953
[TBL] [Abstract][Full Text] [Related]
18. Systems Biology Analysis of the Antagonizing Effects of HIV-1 Tat Expression in the Brain over Transcriptional Changes Caused by Methamphetamine Sensitization.
Basova LV; Kesby JP; Kaul M; Semenova S; Marcondes MCG
Viruses; 2020 Apr; 12(4):. PubMed ID: 32283831
[TBL] [Abstract][Full Text] [Related]
19. The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons.
Langford D; Grigorian A; Hurford R; Adame A; Crews L; Masliah E
J Neurovirol; 2004 Dec; 10(6):327-37. PubMed ID: 15765804
[TBL] [Abstract][Full Text] [Related]
20. In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide.
Carey JW; Pinarci EY; Penugonda S; Karacal H; Ercal N
Free Radic Biol Med; 2011 Mar; 50(6):722-9. PubMed ID: 21172425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
